Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T. Cope
P3.04-01 Combined Plasma cfDNA Mutations and a Serum Proteomic Signature May Identify Non-Responders to Anti PD-1 Treatment in NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Ongoing Role for Starches in Anaesthesia
Anaesthesia
Anesthesiology
Pain Medicine
Related publications
Can IDO Activity Predict Primary Resistance to Anti-Pd-1 Treatment in NSCLC?
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Dynamic Metrics-Based Biomarkers to Predict Responders to Anti-Pd-1 Immunotherapy
British Journal of Cancer
Cancer Research
Oncology
P3.17-01 PD-L1 Expression, EGFR Mutations and ALK Expression in Non-Small Cell Lung Cancer (NSCLC) Patients From Brazil
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P3.04-13 PD-L1-Gene Expression by nCounter Correlates With PD-L1 Protein Expression in Advanced Non-Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Robust Antitumor Effects of Combined Anti-Cd4-Depleting Antibody and Anti-Pd-1/Pd-L1 Immune Checkpoint Antibody Treatment in Mice
Cancer immunology research
Cancer Research
Immunology
P3.04-16 a Seven-Gene Expression Signature Reveals Unique Immune-Phenotypes Related to Major Oncogenic-Drivers in NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Blood Monocyte Frequency May Be a Biomarker for Response to Anti–PD-1
Cancer Discovery
Oncology
MA04.02 Responses and Durability in NSCLC Treated With Pegilodecakin and Anti-Pd-1
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.09-13 Detection of Actionable Mutations in Plasma cfDNA Samples From NSCLC Patients Using a Novel Amplicon-Based Firefly NGS Assay
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary